1 study found for:    21343559 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Study of Neo-adjuvant Use of Vemurafenib Plus Cobimetinib for BRAF Mutant Melanoma With Palpable Lymph Node Metastases
Condition: Melanoma
Interventions: Drug: Vemurafenib;   Drug: Cobimetinib

Indicates status has not been verified in more than two years